En español
NIDA

Dr. Joni Rutter to lead NIDA’s genetics and basic science research division

Rutter to lead institute’s efforts to explore the relationship between genes, environment, and the neuroscience of addiction

May 06, 2014

Joni Rutter

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that Joni Rutter, Ph.D., has been named Division Director for the Division of Basic Neuroscience and Behavioral Research (DBNBR).  For the past three years, Dr. Rutter has served as acting director of DBNBR, leading her staff to build strategic directions for the science supported by the division. 

“We are excited to welcome Dr. Rutter as the new DBNBR Division Director,” said NIDA Director Dr. Nora D. Volkow. “Her extensive experience with how the study of genetics ties into drug abuse strengthens her role as a leader in a division dedicated to fundamentally preventing and stopping drug abuse.”

The division’s primary goal is to support basic biomedical and behavioral research to address the public health problem of drug addiction, including the neurobiological and behavioral mechanisms of drugs of abuse and their consequences.  DBNBR’s research portfolio includes research into the role of drug use in accelerating the progression and the transmission of HIV/AIDS and the effects of chronic pain and its treatments on drug use and addiction processes.  DBNBR also supports research into sex and gender differences as they relate to drug use and addiction.

Dr. Rutter’s career spans 15 years of excellent basic and clinical research in human genetics and the study of genetic and environmental risk factors in the fields of cancer and addiction.  She has earned a national and international reputation for her diverse and unique expertise in more than 50 publications in journals, and she received several scientific achievement awards, including a SmithKline Beecham Student Award in Pharmacology, a Janssen Research Foundation Young Investigator Award, and a Fellowship Achievement Award from the National Cancer Institute.  Rutter has also built, supported, and maintained the NIDA Genetics Consortium, a group of more than 20 investigators who study addiction genetics.

“I am delighted to lead this division’s efforts to advance the basic science of drug abuse and addiction,” said Dr. Rutter.  “My background as a geneticist fits well with NIDA’s commitment to staying at the forefront of scientific discovery, maximizing available resources to foster innovative ideas and scientific collaborations.”

Prior to joining NIDA in 2003, Dr. Rutter received her Ph.D. from the Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire.  Upon completing her doctoral degree, she remained at Dartmouth Medical School as a research associate for a short period of time.  She then accepted a fellowship at the National Cancer Institute within the Division of Cancer Epidemiology and Genetics to fortify her training in human genetics.  Her scientific objective is to integrate genetic principles with the study of how drugs and chemicals act on the brain.


Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): NIDA is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at www.drugabuse.gov. To order publications in English or Spanish, call NIDA's new DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or fax or email requests to 240-645-0227 or drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA's media guide can be found at www.drugabuse.gov/publications/media-guide, and its new easy-to-read website can be found at www.easyread.drugabuse.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

This page was last updated May 2014

News Releases

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

Cite this article

APA style citation

National Institute of Drug Abuse. Dr. Joni Rutter to lead NIDA’s genetics and basic science research division Retrieved from http://www.drugabuse.gov/news-events/news-releases/2014/05/dr-joni-rutter-to-lead-nidas-genetics-basic-science-research-division

press ctrl+c to copy